Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten R Mempel

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Nature|October 16, 2007
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cellsTobias Junt, E Ashley Moseman, Matteo Iannacone, et al.
Cell Host & Microbe|January 11, 2019
HIV-1 Balances the Fitness Costs and Benefits of Disrupting the Host Cell Actin Cytoskeleton Early after Mucosal TransmissionShariq M Usmani, Thomas T Murooka, Maud Deruaz, et al.
Immunity|September 24, 2013
Antigen availability determines CD8⁺ T cell-dendritic cell interaction kinetics and memory fate decisionsSarah E Henrickson, Mario Perro, Scott M Loughhead, et al.
Immunity|February 15, 2015
The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cellsGustavo J Martinez, Renata M Pereira, Tarmo Äijö, et al.
Molecular Pharmacology|December 18, 2013
Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivoMarc Lamphier, Wanjun Zheng, Eicke Latz, et al.
Nature|May 17, 2019
Targeting the CBM complex causes T<sub>reg</sub> cells to prime tumours for immune checkpoint therapyMauro Di Pilato, Edward Y Kim, Bruno L Cadilha, et al.
Neuro-Oncology|October 4, 2015
Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brainKristan E van der Vos, Erik R Abels, Xuan Zhang, et al.
Cancer Cell|June 11, 2024
Interruption of the intratumor CD8<sup>+</sup> T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapyShannon N Geels, Alexander Moshensky, Rachel S Sousa, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Bone degradation machinery of osteoclasts: An HIV-1 target that contributes to bone lossBrigitte Raynaud-Messina, Lucie Bracq, Maeva Dupont, et al.
The Journal of Clinical Investigation|March 17, 2025
Epigenetic therapy sensitizes anti-PD-1 refractory head and neck cancers to immunotherapy rechallengeTingting Qin, Austin K Mattox, Jean S Campbell, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Nature|October 16, 2007
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cellsTobias Junt, E Ashley Moseman, Matteo Iannacone, et al.
Cell Host & Microbe|January 11, 2019
HIV-1 Balances the Fitness Costs and Benefits of Disrupting the Host Cell Actin Cytoskeleton Early after Mucosal TransmissionShariq M Usmani, Thomas T Murooka, Maud Deruaz, et al.
Immunity|September 24, 2013
Antigen availability determines CD8⁺ T cell-dendritic cell interaction kinetics and memory fate decisionsSarah E Henrickson, Mario Perro, Scott M Loughhead, et al.
Immunity|February 15, 2015
The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cellsGustavo J Martinez, Renata M Pereira, Tarmo Äijö, et al.
Molecular Pharmacology|December 18, 2013
Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivoMarc Lamphier, Wanjun Zheng, Eicke Latz, et al.
Nature|May 17, 2019
Targeting the CBM complex causes T<sub>reg</sub> cells to prime tumours for immune checkpoint therapyMauro Di Pilato, Edward Y Kim, Bruno L Cadilha, et al.
Neuro-Oncology|October 4, 2015
Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brainKristan E van der Vos, Erik R Abels, Xuan Zhang, et al.
Cancer Cell|June 11, 2024
Interruption of the intratumor CD8<sup>+</sup> T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapyShannon N Geels, Alexander Moshensky, Rachel S Sousa, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Bone degradation machinery of osteoclasts: An HIV-1 target that contributes to bone lossBrigitte Raynaud-Messina, Lucie Bracq, Maeva Dupont, et al.
The Journal of Clinical Investigation|March 17, 2025
Epigenetic therapy sensitizes anti-PD-1 refractory head and neck cancers to immunotherapy rechallengeTingting Qin, Austin K Mattox, Jean S Campbell, et al.
Pageof 10